Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
According to results of a retrospective, real-world cohort study, glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be beneficial when used as adjunct therapy in the management of Crohns disease (CD) for patients who also have a diagnosis of overweight or obesity
Collier, Peter and Horowitz, David (1984)
By reducing appetite, improving insulin signaling, lowering blood sugar, and slowing stomach emptying, these medications can be powerful tools for individuals struggling with obesity or type 2 diabetes
Most studies have been conducted in animal models or small human trials with high risk of bias, and findings often lack replication in larger, well-controlled clinical studies
Z.IncerpiS.Moosavi-MovahediA
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
